JP2022084699A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022084699A5 JP2022084699A5 JP2022033419A JP2022033419A JP2022084699A5 JP 2022084699 A5 JP2022084699 A5 JP 2022084699A5 JP 2022033419 A JP2022033419 A JP 2022033419A JP 2022033419 A JP2022033419 A JP 2022033419A JP 2022084699 A5 JP2022084699 A5 JP 2022084699A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- indicates
- cycloalkyl
- ring
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims description 19
- 125000000217 alkyl group Chemical group 0.000 claims 69
- 125000003118 aryl group Chemical group 0.000 claims 32
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 29
- 125000005843 halogen group Chemical group 0.000 claims 27
- 125000001424 substituent group Chemical group 0.000 claims 22
- 229910052757 nitrogen Inorganic materials 0.000 claims 20
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 19
- 125000002619 bicyclic group Chemical group 0.000 claims 19
- 125000004432 carbon atom Chemical group C* 0.000 claims 19
- 150000003839 salts Chemical class 0.000 claims 19
- 239000012453 solvate Substances 0.000 claims 18
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 17
- 125000003545 alkoxy group Chemical group 0.000 claims 14
- 125000002950 monocyclic group Chemical group 0.000 claims 11
- 125000004076 pyridyl group Chemical group 0.000 claims 9
- 125000005842 heteroatom Chemical group 0.000 claims 8
- 125000002883 imidazolyl group Chemical group 0.000 claims 8
- 229910052760 oxygen Inorganic materials 0.000 claims 8
- 229910052717 sulfur Inorganic materials 0.000 claims 8
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 7
- 229910052799 carbon Inorganic materials 0.000 claims 7
- 125000004093 cyano group Chemical group *C#N 0.000 claims 7
- 125000000753 cycloalkyl group Chemical group 0.000 claims 7
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 125000003226 pyrazolyl group Chemical group 0.000 claims 4
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 4
- 125000004122 cyclic group Chemical group 0.000 claims 3
- 229910052736 halogen Inorganic materials 0.000 claims 3
- 150000002367 halogens Chemical class 0.000 claims 3
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 206010052779 Transplant rejections Diseases 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 125000000623 heterocyclic group Chemical group 0.000 claims 2
- 125000006704 (C5-C6) cycloalkyl group Chemical group 0.000 claims 1
- 208000023275 Autoimmune disease Diseases 0.000 claims 1
- 208000024172 Cardiovascular disease Diseases 0.000 claims 1
- 208000034486 Multi-organ failure Diseases 0.000 claims 1
- 208000010718 Multiple Organ Failure Diseases 0.000 claims 1
- 206010033645 Pancreatitis Diseases 0.000 claims 1
- 208000027418 Wounds and injury Diseases 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 125000003342 alkenyl group Chemical group 0.000 claims 1
- 230000006378 damage Effects 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 208000014951 hematologic disease Diseases 0.000 claims 1
- 208000027866 inflammatory disease Diseases 0.000 claims 1
- 208000014674 injury Diseases 0.000 claims 1
- 208000017169 kidney disease Diseases 0.000 claims 1
- 210000004072 lung Anatomy 0.000 claims 1
- 208000030159 metabolic disease Diseases 0.000 claims 1
- 208000029744 multiple organ dysfunction syndrome Diseases 0.000 claims 1
- 230000004770 neurodegeneration Effects 0.000 claims 1
- 208000015122 neurodegenerative disease Diseases 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 230000019100 sperm motility Effects 0.000 claims 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 claims 1
- 239000007858 starting material Substances 0.000 description 2
- WZZBNLYBHUDSHF-DHLKQENFSA-N 1-[(3s,4s)-4-[8-(2-chloro-4-pyrimidin-2-yloxyphenyl)-7-fluoro-2-methylimidazo[4,5-c]quinolin-1-yl]-3-fluoropiperidin-1-yl]-2-hydroxyethanone Chemical compound CC1=NC2=CN=C3C=C(F)C(C=4C(=CC(OC=5N=CC=CN=5)=CC=4)Cl)=CC3=C2N1[C@H]1CCN(C(=O)CO)C[C@@H]1F WZZBNLYBHUDSHF-DHLKQENFSA-N 0.000 description 1
- TVTJUIAKQFIXCE-HUKYDQBMSA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynyl-1H-purine-6,8-dione Chemical compound NC=1NC(C=2N(C(N(C=2N=1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C)=O TVTJUIAKQFIXCE-HUKYDQBMSA-N 0.000 description 1
- 229940125851 compound 27 Drugs 0.000 description 1
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662403336P | 2016-10-03 | 2016-10-03 | |
| US62/403,336 | 2016-10-03 | ||
| EP17157785.1 | 2017-02-24 | ||
| EP17157785 | 2017-02-24 | ||
| JP2019517909A JP7101171B2 (ja) | 2016-10-03 | 2017-10-02 | Ｐｒｍｔ５阻害剤として使用するための新規な単環式および二環式環系置換カルバヌクレオシド類似体 |
| PCT/EP2017/074983 WO2018065365A1 (en) | 2016-10-03 | 2017-10-02 | Novel monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as prmt5 inhibitors |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019517909A Division JP7101171B2 (ja) | 2016-10-03 | 2017-10-02 | Ｐｒｍｔ５阻害剤として使用するための新規な単環式および二環式環系置換カルバヌクレオシド類似体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022084699A JP2022084699A (ja) | 2022-06-07 |
| JP2022084699A5 true JP2022084699A5 (https=) | 2023-10-31 |
| JP7576587B2 JP7576587B2 (ja) | 2024-10-31 |
Family
ID=60043171
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019517909A Active JP7101171B2 (ja) | 2016-10-03 | 2017-10-02 | Ｐｒｍｔ５阻害剤として使用するための新規な単環式および二環式環系置換カルバヌクレオシド類似体 |
| JP2022033419A Active JP7576587B2 (ja) | 2016-10-03 | 2022-03-04 | Ｐｒｍｔ５阻害剤として使用するための新規な単環式および二環式環系置換カルバヌクレオシド類似体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019517909A Active JP7101171B2 (ja) | 2016-10-03 | 2017-10-02 | Ｐｒｍｔ５阻害剤として使用するための新規な単環式および二環式環系置換カルバヌクレオシド類似体 |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US11098062B2 (https=) |
| EP (1) | EP3519413A1 (https=) |
| JP (2) | JP7101171B2 (https=) |
| KR (1) | KR102531344B1 (https=) |
| CN (2) | CN115626935B (https=) |
| AU (1) | AU2017338269B2 (https=) |
| BR (1) | BR112019006414A2 (https=) |
| CA (1) | CA3037998A1 (https=) |
| IL (1) | IL265718B (https=) |
| MA (1) | MA46341A (https=) |
| MX (2) | MX2019003843A (https=) |
| PE (1) | PE20190706A1 (https=) |
| PH (1) | PH12019500731A1 (https=) |
| TN (1) | TN2019000087A1 (https=) |
| UA (1) | UA124074C2 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI870767B (zh) | 2015-08-26 | 2025-01-21 | 比利時商健生藥品公司 | 使用作為prmt5抑制劑之新穎經6-6雙環芳香環取代之核苷類似物 |
| TN2019000087A1 (en) | 2016-10-03 | 2020-07-15 | Janssen Pharmaceutica Nv | Novel monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as prmt5 inhibitors |
| TN2019000212A1 (en) | 2017-02-27 | 2021-01-07 | Janssen Pharmaceutica Nv | Use of biomarkers in identifying cancer patients that will be responsive to treatment with a prmt5 inhibitor |
| US11059850B2 (en) | 2017-12-08 | 2021-07-13 | Janssen Pharmaceutica Nv | Spirobicyclic analogues |
| WO2019219805A1 (en) * | 2018-05-16 | 2019-11-21 | Ctxone Pty Ltd | Combination therapy |
| TW202112375A (zh) | 2019-06-06 | 2021-04-01 | 比利時商健生藥品公司 | 使用ｐｒｍｔ５抑制劑治療癌症之方法 |
| WO2021055797A1 (en) * | 2019-09-18 | 2021-03-25 | Prelude Therapeutics, Incorporated | Selective inhibitors of protein arginine methyltransferase 5 (prmt5) |
| EP4069698A1 (en) * | 2019-12-03 | 2022-10-12 | Lupin Limited | Substituted nucleoside analogs as prmt5 inhibitors |
| CN113186153B (zh) * | 2021-04-15 | 2023-09-08 | 南方医科大学 | Prmt5抑制剂在促进精原干细胞损伤再生和增殖中的应用 |
| CN113234079B (zh) * | 2021-04-30 | 2022-02-01 | 上海湃隆生物科技有限公司 | 用作prmt5抑制剂的核苷类似物 |
| CN114740108B (zh) * | 2022-03-28 | 2023-07-14 | 天津键凯科技有限公司 | 一种聚合物修饰抗体类药物的修饰度的测定方法 |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4224438A (en) | 1970-07-14 | 1980-09-23 | Boehringer Mannheim Gmbh | Adenosine-5'-carboxylic acid amides |
| US6143749A (en) * | 1995-06-07 | 2000-11-07 | Abbott Laboratories | Heterocyclic substituted cyclopentane compounds |
| WO2003039523A2 (en) | 2001-11-05 | 2003-05-15 | Exiqon A/S | OLIGONUCLEOTIDES MODIFIED WITH NOVEL α-L-RNA ANALOGUES |
| US7034147B2 (en) | 2001-11-29 | 2006-04-25 | Irm Llc | Nucleoside analog libraries |
| JP2005527502A (ja) | 2002-02-19 | 2005-09-15 | シーブイ・セラピューティクス・インコーポレイテッド | Ａ１アデノシン受容体の部分的および全アゴニスト |
| US20040043959A1 (en) | 2002-03-04 | 2004-03-04 | Bloom Laura A. | Combination therapies for treating methylthioadenosine phosphorylase deficient cells |
| AU2002951247A0 (en) | 2002-09-06 | 2002-09-19 | Alchemia Limited | Compounds that interact with kinases |
| JPWO2005005450A1 (ja) | 2003-07-15 | 2006-08-24 | 三井化学株式会社 | 環状ビスジヌクレオチドの合成方法 |
| EP1694642A4 (en) | 2003-12-19 | 2010-10-06 | Koronis Pharmaceuticals Inc | MUTAGENIC HETEROCYCLES |
| WO2006078752A2 (en) | 2005-01-21 | 2006-07-27 | Methylgene, Inc. | Inhibitors of dna methyltransferase |
| EP2043635A2 (en) | 2006-06-29 | 2009-04-08 | Astex Therapeutics Limited | Pharmaceutical combinations |
| US20080132525A1 (en) | 2006-12-04 | 2008-06-05 | Methylgene Inc. | Inhibitors of DNA Methyltransferase |
| AU2009298802A1 (en) | 2008-09-23 | 2010-04-08 | Alnylam Pharmaceuticals, Inc. | Chemical modifications of monomers and oligonucleotides with cycloaddition |
| KR20120113228A (ko) | 2009-12-18 | 2012-10-12 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 베타 세포 복제 촉진 화합물 및 그 사용 방법 |
| US9145438B2 (en) | 2010-12-03 | 2015-09-29 | Epizyme, Inc. | 7-deazapurine modulators of histone methyltransferase, and methods of use thereof |
| EP2646455A4 (en) | 2010-12-03 | 2014-04-02 | Epizyme Inc | Modulators of histone methyltransferase, and methods of use thereof |
| JP5906253B2 (ja) | 2010-12-16 | 2016-04-20 | アッヴィ・インコーポレイテッド | 抗ウイルス性化合物 |
| EP2694524B1 (en) | 2011-04-04 | 2016-05-18 | The U.S.A. As Represented By The Secretary, Department Of Health And Human Services | 2'-o-aminooxymethyl nucleoside derivatives for use in the synthesis and modification of nucleosides, nucleotides and oligonucleotides |
| JO3154B1 (ar) | 2011-06-17 | 2017-09-20 | Glaxosmithkline Llc | عوامل مضادة لـ trpv4 |
| WO2013062943A1 (en) | 2011-10-24 | 2013-05-02 | Glaxosmithkline Intellectual Property Development Limited | New compounds |
| WO2013151975A1 (en) | 2012-04-02 | 2013-10-10 | Northeastern University | Compositions and methods for the inhibition of methyltransferases |
| WO2014035140A2 (en) | 2012-08-30 | 2014-03-06 | Kainos Medicine, Inc. | Compounds and compositions for modulating histone methyltransferase activity |
| US20140100184A1 (en) | 2012-08-31 | 2014-04-10 | Baylor College Of Medicine | Selective inhibitors of histone methyltransferase dot1l |
| DK2935222T3 (en) | 2012-12-21 | 2019-01-07 | Epizyme Inc | PRMT5 INHIBITORS AND APPLICATIONS THEREOF |
| CA2899363A1 (en) | 2012-12-21 | 2014-06-26 | Epizyme, Inc. | Prmt5 inhibitors and uses thereof |
| CA2894126A1 (en) | 2012-12-21 | 2014-06-26 | Epizyme, Inc. | Prmt5 inhibitors and uses thereof |
| US9745291B2 (en) | 2012-12-21 | 2017-08-29 | Epizyme, Inc. | PRMT5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof |
| CA2942833A1 (en) | 2013-03-15 | 2014-09-18 | Ohio State Innovation Foundation | Inhibitors of prmt5 and methods of their use |
| US10087151B2 (en) | 2014-01-09 | 2018-10-02 | The J. David Gladstone Institutes, A Testimentary Trust Established Under The Will Of J. David Gladstone | Substituted benzoxazine and related compounds |
| US20170198006A1 (en) | 2014-06-25 | 2017-07-13 | Epizyme, Inc. | Prmt5 inhibitors and uses thereof |
| BR112016030787B1 (pt) | 2014-07-01 | 2022-12-20 | Takeda Pharmaceutical Company Limited | Entidade química, composição farmacêutica e seu uso |
| MX2017010844A (es) | 2015-02-24 | 2017-12-07 | Pfizer | Derivados de nucleosidos sustituidos utiles como agentes anticancerosos. |
| TWI870767B (zh) | 2015-08-26 | 2025-01-21 | 比利時商健生藥品公司 | 使用作為prmt5抑制劑之新穎經6-6雙環芳香環取代之核苷類似物 |
| AU2017230658B2 (en) | 2016-03-10 | 2021-03-04 | Janssen Pharmaceutica Nv | Substituted nucleoside analogues for use as PRMT5 inhibitors |
| TN2019000087A1 (en) | 2016-10-03 | 2020-07-15 | Janssen Pharmaceutica Nv | Novel monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as prmt5 inhibitors |
| WO2018065365A1 (en) | 2016-10-03 | 2018-04-12 | Janssen Pharmaceutica Nv | Novel monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as prmt5 inhibitors |
| TN2019000212A1 (en) | 2017-02-27 | 2021-01-07 | Janssen Pharmaceutica Nv | Use of biomarkers in identifying cancer patients that will be responsive to treatment with a prmt5 inhibitor |
| US11059850B2 (en) | 2017-12-08 | 2021-07-13 | Janssen Pharmaceutica Nv | Spirobicyclic analogues |
-
2017
- 2017-10-02 TN TNP/2019/000087A patent/TN2019000087A1/en unknown
- 2017-10-02 EP EP17781060.3A patent/EP3519413A1/en active Pending
- 2017-10-02 KR KR1020197012099A patent/KR102531344B1/ko active Active
- 2017-10-02 US US16/336,934 patent/US11098062B2/en active Active
- 2017-10-02 MX MX2019003843A patent/MX2019003843A/es unknown
- 2017-10-02 UA UAA201904546A patent/UA124074C2/uk unknown
- 2017-10-02 JP JP2019517909A patent/JP7101171B2/ja active Active
- 2017-10-02 BR BR112019006414A patent/BR112019006414A2/pt active Search and Examination
- 2017-10-02 CA CA3037998A patent/CA3037998A1/en active Pending
- 2017-10-02 CN CN202211277466.7A patent/CN115626935B/zh active Active
- 2017-10-02 PE PE2019000723A patent/PE20190706A1/es unknown
- 2017-10-02 CN CN201780061258.4A patent/CN109803971B/zh active Active
- 2017-10-02 AU AU2017338269A patent/AU2017338269B2/en not_active Ceased
- 2017-10-02 MA MA046341A patent/MA46341A/fr unknown
-
2019
- 2019-03-31 IL IL265718A patent/IL265718B/en unknown
- 2019-04-02 MX MX2023005574A patent/MX2023005574A/es unknown
- 2019-04-03 PH PH12019500731A patent/PH12019500731A1/en unknown
-
2021
- 2021-07-16 US US17/378,417 patent/US11993614B2/en active Active
-
2022
- 2022-03-04 JP JP2022033419A patent/JP7576587B2/ja active Active
-
2023
- 2023-10-17 US US18/488,626 patent/US20240124493A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022084699A5 (https=) | ||
| JP2018528946A5 (https=) | ||
| JP7033079B2 (ja) | 芳香族スルホンアミド誘導体 | |
| JP2018524339A5 (https=) | ||
| JP2019521097A5 (https=) | ||
| JP2023544476A5 (https=) | ||
| JP2019518059A5 (https=) | ||
| DE69107215T2 (de) | (2-imidazolin-2-ylamino)chinoxalinderivate und methoden in ihrer anwendung. | |
| JP2019510787A5 (https=) | ||
| JP2019512505A5 (https=) | ||
| JP2018536648A5 (https=) | ||
| JP2023521351A5 (https=) | ||
| WO1999014204A1 (en) | Substituted 1,2,4-triazoles useful for inhibiting cholesteryl ester transfer protein activity | |
| JP2023531709A5 (https=) | ||
| JP2013531070A5 (https=) | ||
| JP2014514290A5 (https=) | ||
| WO2023001028A1 (zh) | 杂芳-3-哌啶二酮类化合物及其应用 | |
| CN102803226A (zh) | 环烷基取代的咪唑衍生物 | |
| EP3458459A1 (en) | Macrocyclic indole derivatives | |
| JP2018535199A5 (https=) | ||
| JP2024517769A5 (https=) | ||
| JP2021513543A5 (https=) | ||
| JP2022545158A5 (https=) | ||
| JP2025503737A5 (https=) | ||
| JP2022529309A5 (https=) |